X-118974796-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001031855.3(LONRF3):āc.16A>Gā(p.Ile6Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000063 in 1,205,583 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 26 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001031855.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LONRF3 | NM_001031855.3 | c.16A>G | p.Ile6Val | missense_variant | 1/11 | ENST00000371628.8 | NP_001027026.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LONRF3 | ENST00000371628.8 | c.16A>G | p.Ile6Val | missense_variant | 1/11 | 1 | NM_001031855.3 | ENSP00000360690.3 | ||
LONRF3 | ENST00000304778.11 | c.16A>G | p.Ile6Val | missense_variant | 1/10 | 1 | ENSP00000307732.7 | |||
LONRF3 | ENST00000481285.5 | n.16A>G | non_coding_transcript_exon_variant | 1/11 | 2 | ENSP00000435426.1 |
Frequencies
GnomAD3 genomes AF: 0.0000357 AC: 4AN: 112024Hom.: 0 Cov.: 24 AF XY: 0.0000292 AC XY: 1AN XY: 34234
GnomAD3 exomes AF: 0.0000363 AC: 6AN: 165223Hom.: 0 AF XY: 0.0000180 AC XY: 1AN XY: 55587
GnomAD4 exome AF: 0.0000658 AC: 72AN: 1093559Hom.: 0 Cov.: 29 AF XY: 0.0000694 AC XY: 25AN XY: 359971
GnomAD4 genome AF: 0.0000357 AC: 4AN: 112024Hom.: 0 Cov.: 24 AF XY: 0.0000292 AC XY: 1AN XY: 34234
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 04, 2023 | The c.16A>G (p.I6V) alteration is located in exon 1 (coding exon 1) of the LONRF3 gene. This alteration results from a A to G substitution at nucleotide position 16, causing the isoleucine (I) at amino acid position 6 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at